Integrating genetic information with the diagnosis of mood disorders in the clinical data allowed us to find a new candidate, SCARF2, at 22q11.2 that we were unable or underpowered to detect in the ascertained bipolar data alone. The gene discussed is SCARF2; the disease is mood disorder.